Last mentioned: Feb 27, 2026
Target Implementation
Anticipated date for the law to take effect, enabling new regulatory and funding mechanisms.
Parliamentary Debate
The bill is expected to move through the House of Commons for debate and potential amendments.
Committee Review
Expected date for health select committee to begin detailed scrutiny of the bill.
Stakeholder Consultation
A formal period for biotech firms, patient advocacy groups, and the NHS to provide feedback on the draft.
Draft Law Unveiled
The Rare Cancers Law is formally introduced as a draft to Parliament.
Draft Law Unveiled
The UK Government releases the initial draft of the Rare Cancers Law focusing on brain tumors.
Policy Consultation
UK Government opens consultation on rare disease frameworks.
Advocacy Surge
Brain tumor charities increase lobbying efforts for legislative reform.
The UK government has unveiled a draft Rare Cancers Law designed to streamline the development and delivery of treatments for incurable brain tumors. This legislative framework aims to bridge the funding gap and accelerate clinical trial access for high-mortality, low-prevalence oncological conditions.
The UK government is advancing a draft Rare Cancers Law designed to fast-track treatments and research for patients with incurable brain tumors. This legislative push aims to dismantle bureaucratic barriers that have historically hindered drug development and clinical trial access for rare oncological conditions.